Top

European Archives of Psychiatry and Clinical Neuroscience

Published in:

01-12-2009 | Original Paper

Heritability of Trail Making Test performance in multiplex schizophrenia families: implications for the search for an endophenotype

Authors: Raúl Mendoza Quiñones, Yuranny Cabral Calderín, Mayelin Domínguez, Tania M. Bravo, Adnelys Reyes Berazaín, Alexander García, Antonio Caballero, Migdyrai Martín Reyes

Published in: European Archives of Psychiatry and Clinical Neuroscience | Issue 8/2009

Abstract

The impairment of the Trail Making Test (TMT) performance as a measure of executive function deficits has been found both in patients with schizophrenia and in their unaffected first-degree relatives, suggesting that it might be considered as a familial vulnerability marker, but its heritability estimates are not well known. This study investigated the genetic heritability of impairments in TMT performance using a sample of 80 schizophrenia patients, 145 unaffected first-degree relatives and 127 healthy controls from families with multiple members with schizophrenia. Consistent with previous reports in the literature, relatives performed in between healthy controls and schizophrenia patients. Based on these results, a variance component-analysis provided small, but significant additive heritability estimates for performance indices relating performance in TMT-version A to TMT-version B. These results showed that this significant but small evidence of heritability on the one hand suggests an association with genetic predisposition to schizophrenia, but that TMT performance is also associated with epigenetic or environmental factors.

Aleman A, Hijman R, de Haan EH, Kahn RS (1999) Memory impairment in schizophrenia: a meta-analysis. Am J Psychiatry 156(9):1358–1366PubMed

Almasy L, Blangero J (1998) Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 62:1198–1211CrossRefPubMed

American Psychiatric Association (1984) Diagnostic and statistical manual of mental disorder, 4th edn. American Psychiatry Association, Washington

Anokhin AP, Heath A, Ralano A (2003) Genetic influences on frontal brain function: WCST performance in twins. Neuroreport 14(15):1975–1978CrossRefPubMed

Arbuthnott K, Frank J (2000) Trail Making Test, part B as a measure of executive control: validation using a set-switching paradigm. J Clin Exp Neuropsychol 22(4):518–528CrossRefPubMed

Asarnow RF, Nuechterlein KH, Subotnik KL, Fogelson DL, Torquato RD, Payne DL, Asamen J, Mintz J, Guthrie D (2002) Neurocognitive impairments in nonpsychotic parents of children with schizophrenia and attention-deficit/hyperactivity disorder: the University of California, Los Angeles Family Study. Arch Gen Psychiatry 59:1053–1060CrossRefPubMed

Aukes MF, Alizadeh BZ, Sistkoorn MM, Selten J, Sinke RJ, Kemmer C, Ophoff RA, Kahn RS (2008) Finding suitable phenotypes for genetic studies of schizophrenia: heritability and segregation analysis. Biol Psychiatry 64(2):128–136CrossRefPubMed

Bonilha L, Molnar C, Horner MD, Anderson B, Forster L, George MS, Nahas Z (2008) Neurocognitive deficits and prefrontal cortical atrophy in patients with schizophrenia. Schizophr Res 101:142–151CrossRefPubMed

Brazo P, Delamillieure P, Morello R, Halbecq I, Marie RM, Dollfus S (2005) Impairments of executive/attentional functions in schizophrenia with primary and secondary negative symptoms. Psychiatry Res 133:45–55CrossRefPubMed

10.

Cornblatt BA, Malhotra AK (2001) Impaired attention as an endophenotype for molecular genetic studies of schizophrenia. Am J Med Genet 105(1):11–15CrossRefPubMed

11.

Dollfus S, Lombardo C, Benali K, Halbecq I, Abadie P, Marie RM, Brazo P (2002) Executive/attentional cognitive functions in schizophrenic patients and their parents: a preliminary study. Schizophr Res 1(53):93–99CrossRef

12.

Egan MF, Goldberg TE, Gscheidle T, Weirich M, Rawlings R, Hyde TM, Bigelow L, Weinberger DR (2001) Relative risk for cognitive impairments in siblings of patients with schizophrenia. Biol Psychiatry 50:98–107CrossRefPubMed

13.

Franke P, Maier W, Hardt J, Hain C (1993) Cognitive functioning and anhedonia in subjects at risk for schizophrenia. Schizophr Res 10:77–84CrossRefPubMed

14.

Gilvarry CM, Rusell A, Hemsley D, Murray RM (2000) Trail Making Test performance in the first degree relatives of schizophrenic and affected psychotic patients. Cogn Neuropsychiatry 5:219–234CrossRef

15.

González-Blanch C, Álvarez-Jiménez M, Rodríguez-Sánchez JM, Pérez-Iglesias R, Vázquez-Barquero JL, Crespo-Facorro B (2006) Cognitive functioning in the early course of first-episode schizophrenia spectrum disorders. Eur Arch Psychiatry Clin Neurosci 256:364–371CrossRefPubMed

16.

Gottesman II, Gould TD (2003) The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 160:636–645CrossRefPubMed

17.

Heinrich RW, Zakzanis KK (1998) Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 12:426–445CrossRef

18.

Keefe RS, Silverman JM, Roitman SE, Harvey PD, Duncan MA, Alroy D, Siever LJ, Davis KL, Mohs RC (1994) Performance of nonpsychotic relatives of schizophrenic patients on cognitive tests. Psychiatry Res 53:1–12CrossRefPubMed

19.

Kremen WS, Seidman LJ, Pepple JR, Lyons MJ, Tsuang MT, Faraone SV (1994) Neuropsychological risk indicators for schizophrenia: a review of family studies. Schizophr Bull 20(1):103–119PubMed

20.

Ma X, Wang Q, Sham PC, Liu X, Rabe-Hesketh S, Sun X, Hu J, Meng H, Chen W, Chen EYH, Deng W, Chan RCK, Murray R, Collier D, Li T (2007) Neurocognitive deficits in first-episode schizophrenic patients and their first-degree relatives. Am J of Med Genet B Neuropsychiatr Genet 144B:407–416CrossRef

21.

Maxwell ME (1992) Family interview for genetic studies. Clinical Neurogenetic Branch, Intramural Research Program, NIMH

22.

Meyer-Lindenberg A, Poline JB, Kohn PD, Holt JL, Egan MF, Weinberger DR, Berman KF (2001) Evidence for abnormal cortical functional connectivity during working memory in schizophrenia. Am J Psychiatry 158:1809–1817CrossRefPubMed

23.

Pantelis C, Barber FZ, Barnes TRE, Nelson HE, Owen SM, Robbins TW (1999) Comparison of set-shifting ability in patients with chronic schizophrenia and frontal lobe damage. Schizophr Res 37(3):251–270CrossRefPubMed

24.

Periáñez JA, Ríos-Lago M, Rodríguez-Sánchez JM, Adrover-Roig D, Sánchez-Cubillo I, Cresco-Facorro B, Quemada JL, Barceló F (2007) Trail Making in traumatic brain injury, schizophrenia, and normal ageing: sample comparisons and normative data. Arch Clin Neuropsychol 22:433–447CrossRefPubMed

25.

Pogue-Geile MF, Garrett AH, Brunke JJ, Hall JK (1991) Neuropsychological impairments are increased in siblings of schizophrenic patients. Schizophr Res 4:390CrossRef

26.

Reitan RM (1958) Validity of Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 8:271–276CrossRef

27.

Riedel M, Spellmann I, Strassnig M, Douhet A, Dehning S, Opgen-Rhein M, Valdevit R, Engel R, Kleindienst N, Müller N, Möller H (2007) Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms. Eur Arch Psychiatry Clin Neurosci 257:360–370CrossRefPubMed

28.

Ritter LM, Meador-Woodruff JH, Dalack GW (2004) Neurocognitive measures of prefrontal cortical dysfunction in schizophrenia. Schizophr Res 68:65–73CrossRefPubMed

29.

Sitskoorn MM, Aleman A, Ebisch SJH, Apples MCM, Kahn RS (2004) Cognitive deficits in relatives of patients with schizophrenia: a meta-analysis. Schizophr Res 71:285–295CrossRefPubMed

30.

Snitz BE, Macdonald AW, Carter CS (2006) Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes. Schizophr Bull 32:179–194CrossRefPubMed

31.

Spellmann I, Müller N, Musil R, Zill P, Douhet A, Dehning S, Cerovecki A, Bondy B, Möller H, Riedel M (2008) Associations of SNAP-25 polymorphisms with cognitive dysfunctions in Caucasian patients with schizophrenia during a brief trail of treatment with atypical antipsychotics. Eur Arch Psychiatry Clin Neurosci 258:335–344CrossRefPubMed

32.

Swan GE, Carmelli D (2002) Evidence for genetic mediation of executive control: a study of aging male twins. J Gerontol B Psychol Sci Soc Sci 57:133–143

33.

Szöke A, Schurhoff F, Mathieu F, Meary A, Ionescu S, Leboyer M (2005) Tests of executive functions in first-degree relatives of schizophrenic patients: a meta-analysis. Psychol Med 35:771–782CrossRefPubMed

34.

Taylor J (2007) Heritability of Wisconsin Card Sorting Test (WCST) and Stroop Color-Word Test performance in normal individuals: implications for the search for endophenotypes. Twin Res Hum Genet 10(6):829–834CrossRefPubMed

35.

Thompson JL, Watson JR, Steinhauer SR, Goldstein G, Pogue-Geile MF (2005) Indicators of genetic liability to schizophrenia: a sibling study of neuropsychological performance. Schizophr Bull 31(1):85–96CrossRefPubMed

36.

Tuulio-Henriksson A, Haukka J, Partonen T, Varilo T, Paunio T, Ekelund J, Cannon TD, Lönnqvist J (2002) Heritability of neurocognitive functions and number of quantitative trait loci contributing to them in families with schizophrenia. Am J Med Genet B Neuropsychiatr Genet 114:483–490CrossRef

37.

Vázquez-Barquero JL (1992) Report on the Spanish Translation of the SCAN, Schedules and Glossary. Informe a la Organización Mundial de la Salud. Unidad de Investigación en Psiquiatría Social de Cantabria, Santander

38.

Velligan DI, DiCocco M, Bow-Thomas CC, Cadle C, Glahn DC, Miller AL, Bigg MM, Shores-Wilson K, McKenzie CA, Crismon ML (2004) A brief cognitive assessment for use with schizophrenia patients in community clinics. Schizophr Res 71:273–283CrossRefPubMed

39.

Waldman ID (2005) Statistical approaches to complex phenotypes: evaluating neuropsychological endophenotypes for attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1347–1356CrossRefPubMed

40.

Yurgelun-Todd DA, Kinney DK (1993) Patterns of neuropsychological deficits that discriminate schizophrenic individuals from siblings and control subjects. J Neuropsychiatry 5:294–300

41.

Zalla T, Joyce C, Szoke A, Schurhoff F, Pillon B, Komano O, Perez-Diaz F, Bellivier F, Alter C, Duboise B, Rouillon F, Houde O, Leboyer M (2004) Executive dysfunctions as potential markers of familial vulnerability to bipolar disorder and schizophrenia. Psychiatry Res 121:207–217CrossRefPubMed

Title: Heritability of Trail Making Test performance in multiplex schizophrenia families: implications for the search for an endophenotype
Authors: Raúl Mendoza Quiñones
Yuranny Cabral Calderín
Mayelin Domínguez
Tania M. Bravo
Adnelys Reyes Berazaín
Alexander García
Antonio Caballero
Migdyrai Martín Reyes
Publication date: 01-12-2009
Publisher: D. Steinkopff-Verlag
Published in: European Archives of Psychiatry and Clinical Neuroscience / Issue 8/2009
Print ISSN: 0940-1334
Electronic ISSN: 1433-8491
DOI: https://doi.org/10.1007/s00406-009-0012-6

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Heritability of Trail Making Test performance in multiplex schizophrenia families: implications for the search for an endophenotype

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 8/2009

Review of the 6th symposium for the search for the causes of schizophrenia, Sao Paulo, Brazil, 3–6 February 2009

Neuropsychological assessment of driving ability and self-evaluation: a comparison between driving offenders and a control group

Reduced hippocampal neurogenesis in the GR+/− genetic mouse model of depression

Driving simulator performance and psychomotor functions of schizophrenic patients treated with antipsychotics

Temperamental predictors of externalizing problems among boys and girls: a longitudinal study in a high-risk sample from ages 3 months to 15 years

The effect of the COMT val158met polymorphism on neural correlates of semantic verbal fluency